Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

[Nle4, D-Phe7]-alpha-melanocyte stimulating hormone

EU orphan designation number: EU/3/08/545   
Active ingredient: [Nle4, D-Phe7]-alpha-melanocyte stimulating hormone
Indication: Treatment of congenital erythropoietic porphyria
Sponsor: Clinuvel (UK) Limited
C/o- Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/05/2008 Centralised Orphan - Designation EMEA/OD/019/08 (2008)1899 of 08/05/2008
28/04/2009 Other procedure